Overview

BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)

Status:
Completed

Trial end date:
2006-10-01

Target enrollment:

Participant gender:

Summary

Many patients with exacerbations of heart failure have significant concomitant kidney dysfunction. The combination of these two conditions makes pharmacological management difficult. In this study, we plan to randomize patients with heart failure and kidney dysfunction to receive infusions of Natrecor (B-type Natriuretic Peptide)--which may be beneficial to the management of these two diseases--or placebo.

Phase:

Phase 4

Details

Lead Sponsor:

Stanford University

Collaborator:

Scios, Inc.

Treatments:

Natriuretic Peptide, Brain